Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical PracticeGuideline Number 8; Quick Reference Guide for Clinicians Number 8; Treating Your Enlarged Prostate: Patient Guide

摘要

Benign prostatic hyperplasia (BPH) is the most common benign neoplasm in theaging human male. The prevalence of histologically identifiable BPH increases progressively. By the age of 60, more than 50 percent of all men will have microscopic evidence of BPH. By age 85, approximately 90 percent of men will have some degree of BPH. It has been estimated that, by the age of 80, one in every four males in the United States will require treatment of symptomatic BPH. The Clinical Practice Guideline was developed to apply to the typical man over age 50 with symptoms of prostatism, but with no significant medical morbidities such as diabetes or other known causes of voiding dysfunction such as urethral stricture or neurogenic bladder. The men to whom the guideline applies would not be at increased risk from surgery or the other recognized treatments for BPH. At least two-thirds of BPH patients encountered in most clinical settings conform to this patient profile.